As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
A ‘GAME-changing’ drug which could slow down Alzheimer’s disease is being considered for potential use on the NHS. The daily medication, called hydromethylthionine mesylate ...
Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.
The treatment, Lecanemab ... Lecanemab is revolutionary for treating Alzheimer's dementia, Jing said, as the drug treats the disease itself rather than the symptoms. "There is still no cure ...